Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #234007 on Biotech Values
DewDiligence
08/02/20 5:56 PM
#234008 RE: 57_2001 #234007
Moderna claimed the LNP used to make mRNA-1273, its Covid-19 vaccine candidate, is not covered by the Arbutus patent. “Moderna is not aware of any significant intellectual property impediments for any products we intend to commercialize, including mRNA-1273,” the company said.